Journal Article

Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial

Hunt, Beverley J, Warwick, David, Lawton, Rebecca, Hamady, Zaed, Everington, Tamara, Hudson, Jemma, Dhillon, Karen, Stansby, Gerrard, Bradbury, Andrew, Gohel, Manjit S, Davies, Alun H, Shalhoub, Joseph, Baker, Christopher, Norrie, John

2020

Overview

AbstractObjectivesTo investigate whether the use of graduated compression stockings (GCS) offers any adjuvant benefit when pharmaco-thromboprophylaxis is used for venous thromboembolism prophylaxis in patients undergoing elective surgery.DesignOpen, multicentre, randomised, controlled, non-inferiority trial.SettingSeven National Health Service tertiary hospitals in the United Kingdom.Participants1905 elective surgical inpatients (≥18 years) assessed as being at moderate or high risk of venous thromboembolism were eligible and consented to participate.InterventionParticipants were randomly assigned (1:1) to receive low molecular weight heparin (LMWH) pharmaco-thromboprophylaxis alone or LMWH pharmaco-thromboprophylaxis and GCS.Outcome measuresThe primary outcome was imaging confirmed lower limb deep vein thrombosis with or without symptoms, or pulmonary embolism with symptoms within 90 days of surgery. Secondary outcome measures were quality of life, compliance with stockings and LMWH, lower limb complications related to GCS, bleeding complications, adverse reactions to LMWH, and all cause mortality.ResultsBetween May 2016 and January 2019, 1905 participants were randomised. 1858 were included in the intention to treat analysis (17 were identified as ineligible after randomisation and 30 did not undergo surgery). A primary outcome event occurred in 16 of 937 (1.7%) patients in the LMWH alone group compared with 13 of 921 (1.4%) in the LMWH and GCS group. The risk difference between the two groups was 0.30% (95% confidence interval −0.65% to 1.26%). Because the 95% confidence interval did not cross the non-inferiority margin of 3.5% (P<0.001 for non-inferiority), LMWH alone was confirmed to be non-inferior.ConclusionsFor patients who have elective surgery and are at moderate or high risk of venous thromboembolism, administration of pharmaco-thromboprophylaxis alone is non-inferior to a combination of pharmaco-thromboprophylaxis and GCS. These findings indicate that GCS might be unnecessary in most patients undergoing elective surgery.Trial registrationISRCTN13911492.

• Publisher: British Medical Journal Publishing Group,BMJ Publishing Group LTD,BMJ Publishing Group Ltd
• Subject: Adjuvants, Pharmaceutic / Adult / Aged / Anticoagulants / Anticoagulants - therapeutic use / Combined Modality Therapy / Compression / Compression therapy / Disease prevention / Elective surgery / Elective Surgical Procedures - adverse effects / Embolism / Embolisms / Female / Heparin / Heparin, Low-Molecular-Weight - therapeutic use / Humans / Male / Middle Aged / Molecular weight / Patients / Postoperative Complications - etiology / Postoperative Complications - prevention & control / Quality of life / Risk assessment / Stockings, Compression / Surgery / Systematic review / Thromboembolism / Thrombosis / Treatment Outcome / Ultrasonic imaging / Veins & arteries / Venous Thromboembolism - etiology / Venous Thromboembolism - prevention & control